Biosimilars and Interchangeable Biologics: Strategic Elements - Image 1

£230.60

CRC Press Biosimilars and Interchangeable Biologics: Strategic Elements

Name: Biosimilars and Interchangeable Biologics: Strategic Elements
Brand: CRC Press
Price: 230.6 GBP
Availability: InStock

Biomedical Engineering

Price History & Forecast

Last 18 days • 18 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price

Price Analysis

Most common price: £231 (18 days, 100.0%)

Price range: £231 - £231

Price levels: 1 different prices over 18 days

Description

What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Strategic Elements explores the strategic planning side of biosimilar drugs and targets issues surrounding biosimilars that are linked to legal matters. This includes principal patents and intellectual property, regulatory pathways, and concerns about affordability on a global scale. It addresses the complexity of biosimilar products, and it discusses the utilization of biosimilars and related biological drugs in expanding world markets. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume examines the science, technology, finance, legality, ethics, and politics of biosimilar drugs. It considers strategic planning elements that include an overall understanding of the history and the current status of the art and science of biosimilars, and it provides detailed descriptions of the legal, regulatory, and commercial characteristics. The book also presents a global strategy on how to build, take to market, and manage the next generation of biosimilars throughout their life cycle.

Product Specifications

Brand: CRC Press
Format: Hardcover
ASIN: 1498743471
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Biomedical Engineering
Domain: Amazon UK
Release Date: 27 January 2016
Listed Since: 04 May 2015

Barcode

No barcode data available

CRC Press Biosimilars and Interchangeable Biologics: Strategic Elements

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars Development Strategies: Fast to Market Approaches

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biopharmaceuticals: Challenges and Opportunities

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

CRC Press - Biosimilar Drug Product Development Book

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

ASHP Biosimilars and Biologics - Implementation and Monitoring

Handbook of Bioequivalence Testing (Drugs and the Pharmaceutical Sciences)

mRNA Therapeutics: Fast-to-Market Strategies

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Patient-Focused Network Integration in BioPharma: Strategic Imperatives for the Years Ahead

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

Wiley - Biological Drug Products: Development and Strategies

Gene and Cell Therapies: Market Access and Funding (Pharmaceuticals, Health Economics and Market Access)

Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead

Current Applications of Pharmaceutical Biotechnology: 171 (Advances in Biochemical Engineering/Biotechnology, 171)

Developability of Biotherapeutics: Computational Approaches